Regeneron Pharmaceuticals, Inc.

13F Filings History

Latest 13F report
Q2 2025 - Aug 1, 2025
Value $
$1.49B
Signature - Title
Leonard Brooks - Senior Vice President, Treasurer
Location
Tarrytown, NY
Summary
This page shows a list of all the recent 13F filings made by Regeneron Pharmaceuticals, Inc.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Regeneron Pharmaceuticals, Inc. reported 4 stock holdings with total value $1.49B as of Q2 2025. Top holdings included ALNY, NTLA, ACET, and ADVM.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q2 2025 4 $1.49B $0 -$6.3M -$6.3M ALNY, NTLA, ACET, ADVM 13F-HR 8/1/2025, 04:09 PM
Q1 2025 6 $1.23B $0 $0 ALNY, NTLA, TSVT, ADVM, ACET 13F-HR 5/2/2025, 04:15 PM
Q4 2024 6 $1.09B $0 $0 ALNY, NTLA, TSVT, ACET, ADVM 13F-HR 2/7/2025, 04:36 PM